11 products to Category H from March 2026
Community Pharmacy England (CPE) have published products that DHSC are moving from Category C to Category H It seems to be a phased approach so at the moment there are only the following 11 products
11 products to Category H from March 2026
- Cinchocaine 5mg / Hydrocortisone 5mg suppositories
- Doxazosin 4mg modified-release tablets
- Etodolac 600mg modified-release tablets
- Isosorbide mononitrate 25mg modified-release capsules
- Nicotine 4mg medicated chewing gum sugar free
- Omeprazole 10mg dispersible gastro-resistant tablets
- Omeprazole 20mg dispersible gastro-resistant tablets
- Omeprazole 40mg dispersible gastro-resistant tablets
- Pseudoephedrine hydrochloride 60mg tablets
- Ursodeoxycholic acid 500mg tablets
- Verapamil 120mg modified-release tablets
The drugs will be available as both a generic and branded product DHSC will continue to determine whether a generic medicine is eligible for inclusion in either Category A or Category M, provided it meets the relevant entry criteria. If a generic medicine does not meet the criteria for Category A or Category M, it will instead be considered for placement in Category H.